NanoCellect Biomedical Expands Product Distribution to Denmark, Finland, Iceland, Norway and Sweden
San Diego, Calif., November 20, 2019 — NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell isolation & sorting solutions for cell-based assays, today announced an exclusive agreement with Denmark-based RAMCON to distribute NanoCellect’s WOLF® Cell Sorter, N1 Single-Cell Dispenser, consumables and software in Denmark, Finland, Iceland, Norway and Sweden.
NanoCellect’s microfluidic solutions allow researchers to analyze and separate biological samples one cell at a time, enabling researchers to isolate cells or populations of interest from the rest of the sample more gently than conventional technology.
“We have seen a significant level of interest and demand for our cell sorting technology in Scandanavia,” said Chris Neary, CEO of NanoCellect Biomedical, Inc. “As we continue to expand our international distribution channels, we believe RAMCON’s commitment to sales, support and service makes them the perfect partner for us to help get our products into the region’s labs that need them.”
“NanoCellect’s microfluidic cell sorting technology is very innovative, and we’re delighted to be adding their product offerings growing list of technology solutions for our customer base,” said Jesper Hardt, CEO of RAMCON.
For more information about NanoCellect’s and its products, please visit, https://nanocellect.com. For more information about RAMCON, please visit, http://www.RAMCON.dk.
Established in 1988, RAMCON is a leading distributor with more than 50 employees in sales, support and service. The company focuses on the industrial, medical, chemical and life science markets in the Nordic countries. For more information, please visit, www.RAMCON.dk.